MaxCyte to Participate in Upcoming Investor Conferences

(marketscreener.com) ROCKVILLE, Md., Nov. 02, 2022 -- MaxCyte, Inc., , a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced Company management will participate in the...https://www.marketscreener.com/quote/stock/MAXCYTE-INC-26786499/news/MaxCyte-to-Participate-in-Upcoming-Investor-Conferences-42177372/?utm_medium=RSS&utm_content=20221102